NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

403 hedge funds and large institutions have $7.57B invested in Neurocrine Biosciences in 2021 Q4 according to their latest regulatory filings, with 72 funds opening new positions, 141 increasing their positions, 140 reducing their positions, and 57 closing their positions.

Holders
403
Holders Change
+10
Holders Change %
+2.54%
% of All Funds
6.22%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
72
Increased
141
Reduced
140
Closed
57
Calls
$44.6M
Puts
$52M
Net Calls
-$7.33M
Net Calls Change
-$60.4M

Top Buyers

1
BlackRock
1
BlackRock
New York
$977M
2
Ameriprise
2
Ameriprise
Minnesota
$60.2M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$37.2M
4
California Public Employees Retirement System
4
California Public Employees Retirement System
California
$53.6M
5
APM
5
Avidity Partners Management
Texas
$107M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$57.5M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$634M
3
PAMS
3
Pictet Asset Management (Switzerland)
Switzerland
$35M
4
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$9.41M
5
WP
5
Woodline Partners
California
$10.9M
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$977M 11,476,545 +1,258,312 +12%
Vanguard Group
2
Vanguard Group
Pennsylvania
$748M 8,787,991 -100,479 -1%
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$634M 7,445,839 -1,540,472 -17%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$371M 4,359,645 -104,640 -2%
State Street
5
State Street
Massachusetts
$317M 3,727,141 +266,073 +8%
BG
6
Bellevue Group
Switzerland
$271M 3,180,551 +176,500 +6%
JPMorgan Chase & Co
7
JPMorgan Chase & Co
New York
$254M 2,981,099 +291,601 +11%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$159M 1,861,989 -40,058 -2%
EVM
9
Eaton Vance Management
Massachusetts
$157M 1,846,915 -38,991 -2%
Goldman Sachs
10
Goldman Sachs
New York
$130M 1,524,515 +81,017 +6%
Renaissance Technologies
11
Renaissance Technologies
New York
$121M 1,423,664 +67,700 +5%
DCP
12
DSM Capital Partners
Florida
$120M 1,408,197 -104,913 -7%
DM
13
Deerfield Management
New York
$117M 1,377,945 +235,530 +21%
APM
14
Avidity Partners Management
Texas
$107M 1,260,000 +411,100 +48%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$105M 1,237,548 +25,327 +2%
RSCM
16
Rock Springs Capital Management
Maryland
$94.1M 1,105,000 +53,500 +5%
Franklin Resources
17
Franklin Resources
California
$82.1M 963,821 -203 -0%
Brown Advisory
18
Brown Advisory
Maryland
$79.8M 936,484 +143,477 +18%
O
19
OrbiMed
New York
$79.4M 931,915 -260,100 -22%
CAM
20
Congress Asset Management
Massachusetts
$77.4M 909,088 -102,684 -10%
Northern Trust
21
Northern Trust
Illinois
$74.5M 874,411 -39,388 -4%
Citadel Advisors
22
Citadel Advisors
Florida
$70.1M 822,829 -21,172 -3%
Norges Bank
23
Norges Bank
Norway
$65.4M 768,416 +3,997 +0.5%
Ameriprise
24
Ameriprise
Minnesota
$60.2M 707,456 +508,925 +256%
Westfield Capital Management
25
Westfield Capital Management
Massachusetts
$60.1M 706,226 -16,952 -2%
1
2 3 4 5